Abstract
Controlled release tablet of Salbutamol has been shown to be clinically superior to the standard 4 mg Salbutamol tablets given 3–4 times daily. Salbutamol-Sulphate sustained release tablets based on two marketed polymers, Eudragit and Methocel, is presented here. Effect of water insoluble diluents on in vitro drug release was evaluated.